Morgan Stanley  

(Public, NYSE:MS)   Watch this stock  
Find more results for ms
+0.25 (0.51%)
Real-time:   2:24PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 49.29 - 49.76
52 week 39.97 - 51.52
Open 49.61
Vol / Avg. 3.26M/7.83M
Mkt cap 89.24B
P/E 13.64
Div/yield 0.25/2.03
EPS 3.62
Shares 1.81B
Beta 1.66
Inst. own 63%
Jan 15, 2018
Q4 2017 Morgan Stanley Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 17, 2017
Mediclinic International PLC at Morgan Stanley Roadshow - London
Nov 3, 2017
Morgan Stanley Fixed Income Investor Conference Call
Oct 17, 2017
Q3 2017 Morgan Stanley Earnings Release
Oct 17, 2017
Q3 2017 Morgan Stanley Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 16.60% 16.13%
Operating margin 23.08% 23.32%
EBITD margin - 27.89%
Return on average assets 0.84% 0.76%
Return on average equity 9.59% 8.09%
Employees 57,702 -
CDP Score - A-


1585 Broadway
NEW YORK, NY 10036-8200
United States - Map
+1-212-7614000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Morgan Stanley is a financial holding company. The Company's segments include Institutional Securities, Wealth Management and Investment Management. The Company's Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients. The Company's Wealth Management business segment provides an array of financial services and solutions to individual investors and small-to-medium sized businesses and institutions covering brokerage and investment advisory services, market-making activities in fixed income securities, financial and wealth planning services, annuity and insurance products, credit and other lending products, banking and retirement plan services. The Company's Investment Management business segment provides a range of investment strategies and products.

Officers and directors

James P. Gorman Chairman of the Board, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Colm Kelleher President
Age: 59
Bio & Compensation  - Reuters
Jonathan M. Pruzan Chief Financial Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
Jeffrey S. Brodsky Chief Human Resource Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Keishi Hotsuki Executive Vice President, Chief Risk Officer
Age: 54
Bio & Compensation  - Reuters
Eric F. Grossman Executive Vice President, Chief Legal Officer
Age: 50
Bio & Compensation  - Reuters
Daniel A. Simkowitz Head of Investment Management
Age: 51
Bio & Compensation  - Reuters
Patrick J. Willcutts Corporate Retirement Director
Bio & Compensation  - Reuters
Thomas H. Glocer Lead Independent Director
Age: 57
Bio & Compensation  - Reuters
Nobuyuki Hirano Director
Age: 66
Bio & Compensation  - Reuters